JP2023547396A5 - - Google Patents
Info
- Publication number
- JP2023547396A5 JP2023547396A5 JP2023524715A JP2023524715A JP2023547396A5 JP 2023547396 A5 JP2023547396 A5 JP 2023547396A5 JP 2023524715 A JP2023524715 A JP 2023524715A JP 2023524715 A JP2023524715 A JP 2023524715A JP 2023547396 A5 JP2023547396 A5 JP 2023547396A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105013P | 2020-10-23 | 2020-10-23 | |
| US63/105,013 | 2020-10-23 | ||
| PCT/US2021/056127 WO2022087326A1 (en) | 2020-10-23 | 2021-10-22 | Heterocyclic compounds and their use for treatment of helminthic infections and diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547396A JP2023547396A (ja) | 2023-11-10 |
| JP2023547396A5 true JP2023547396A5 (https=) | 2024-10-29 |
| JPWO2022087326A5 JPWO2022087326A5 (https=) | 2024-10-29 |
Family
ID=78676658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524715A Pending JP2023547396A (ja) | 2020-10-23 | 2021-10-22 | 蠕虫感染及び疾患の処置のための複素環式化合物及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240025891A1 (https=) |
| EP (1) | EP4232449A1 (https=) |
| JP (1) | JP2023547396A (https=) |
| KR (1) | KR20230092972A (https=) |
| CN (1) | CN116547282A (https=) |
| WO (1) | WO2022087326A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230043904A (ko) | 2020-07-24 | 2023-03-31 | 엘랑코 유에스 인코포레이티드 | 이속사졸린 화합물 및 이의 중간체의 제조 공정 |
| CN116744917A (zh) | 2020-09-04 | 2023-09-12 | 礼蓝美国公司 | 适口调配物 |
| CA3219348A1 (en) | 2021-05-27 | 2022-12-01 | Anthony B. Pinkerton | Checkpoint kinase 1 (chk1) inhibitors and uses thereof |
| KR20250025634A (ko) * | 2022-05-24 | 2025-02-24 | 바운드리스 바이오, 인크. | 피리딘 관문 키나제 1(chk1) 억제제 및 그의 용도 |
| EP4626433A1 (en) * | 2022-11-29 | 2025-10-08 | Boundless Bio, Inc. | Checkpoint kinase 1 (chk1) inhibitors combinations and uses thereof |
| CN115819429A (zh) * | 2022-12-13 | 2023-03-21 | 成都睿智化学研究有限公司 | 一种5-氯-2,3-二氢呋喃[2,3-c]吡啶的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2140543T3 (es) * | 1993-08-13 | 2000-03-01 | Zeneca Ltd | Derivados de tia- y oxadiazol y su uso como fungicidas o insecticidas. |
| US5614470A (en) * | 1994-04-01 | 1997-03-25 | Sankyo Company, Limited | 13-substituted milbemycin derivatives, their preparation and their use |
| US20050227989A1 (en) * | 2004-04-13 | 2005-10-13 | Icagen, Inc. | Polycyclic thiazoles as potassium ion channel modulators |
| KR20140071472A (ko) * | 2011-10-04 | 2014-06-11 | 인스티튜트 포 헤퍼타이티스 앤드 바이러스 리서치 | 간세포 암종을 포함하는 암의 저해제로서 그리고 간염 바이러스 복제의 저해제로서의 치환된 아미노티아졸 |
| US9695193B2 (en) * | 2013-06-26 | 2017-07-04 | The Trustees Of Columbia University In The City Of New York | Inhibitors of Plasmodium falciparum equilibrative nucleoside transporter type I as anti-parasitic compounds |
| WO2016144678A1 (en) * | 2015-03-12 | 2016-09-15 | E I Du Pont De Nemours And Company | Heterocycle-substituted bicyclic azole pesticides |
| US10913734B2 (en) * | 2016-07-11 | 2021-02-09 | Baruch S. Blumberg Institute | Substituted aminothiazoles |
| US11505548B2 (en) * | 2019-04-26 | 2022-11-22 | Celgene Corporation | Heterocyclic compounds and their use for treatment of helminthic infections and diseases |
-
2021
- 2021-10-22 US US18/032,998 patent/US20240025891A1/en active Pending
- 2021-10-22 EP EP21810484.2A patent/EP4232449A1/en active Pending
- 2021-10-22 JP JP2023524715A patent/JP2023547396A/ja active Pending
- 2021-10-22 WO PCT/US2021/056127 patent/WO2022087326A1/en not_active Ceased
- 2021-10-22 CN CN202180071227.3A patent/CN116547282A/zh active Pending
- 2021-10-22 KR KR1020237016754A patent/KR20230092972A/ko active Pending